May 20 |
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
|
May 20 |
Regeneron Eylea generics approved by FDA
|
May 17 |
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
|
May 17 |
Regeneron wins temporary restraining order preventing Eylea generic launch
|
May 16 |
These 2 No-Brainer Growth Stocks Are Breaking New Ground
|
May 14 |
Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
|
May 14 |
Evercore says biotech ‘winter is finally thawing’
|
May 13 |
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
|
May 13 |
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
|
May 13 |
Pipeline Moves: Phase III completion for Corcept’s relaorilant
|